Initial Investigation of [18F]P17-059 in ... - Cure Parkinson's
Initial Investigation of [18F]P17-059 in Parkinson's Disease Patients and Healthy Volunteers - march 2019
Written by
Farooqji
To view profiles and participate in discussions please or .
2 Replies
•
Looks like an imaging agent by this company with no website:
Five Eleven Pharma Philadelphia PA
you are right. Its CEO David Alexoff
has authored/co-authored many research papers
Not what you're looking for?
You may also like...
Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease - 2019
mentioned Trehalose a few times in these forums...
Virtual Reality Training Improves Balance for Patients With Parkinson Disease
Meta-Regression of a Randomized Controlled Trial 2022...
Caffeine shown to affect brain dopamine function in patients with Parkinson's disease
function in patients with Parkinson's disease, shows a new international study led by the University
Free Webinar: “Zhittya's Parkinson's Disease Research Study: 6-Month Patient Follow-Up Report”
in viewing the webinar, please register at:...
